Dr Shafqat Inam
Dr Shafqat Inam is a consultant haematologist and BMT physician at the Alfred Hospital. His clinical and research focus is stem cell transplantation, CAR T cell therapy and the application of novel cell and immune therapies in the treatment of lymphoma, leukaemia, and myeloma.
Dr Pietro Di Ciaccio
Pietro Di Ciaccio is a clinical haematologist at Sydney Adventist and St Vincent’s Private Hospitals, and laboratory haematologist at Douglass Hanly Moir Pathology. He has particular clinical and research interests in lymphomas, and haematological cancers in pregnant women.
Clinical A/Prof Anna Johnston
Anna is a staff specialist haematologist at the Royal Hobart Hospital, Head of Clinical Haematology and the Tasmanian Statewide Bone Marrow Transplant service. She trained in Sydney, Canberra and France before returning to Hobart in 2011. Her main research interest is haematological malignancy, particularly lymphoma and supportive care. Anna is an active member of the […]
Lymphoma & Leukaemia Watch 52 – Long term survivorship after CAR T cell therapy
Lymphoma & Leukaemia Research Review, Issue 100
Lymphoma & Leukaemia Watch 50 – Transplantation for Hodgkin lymphoma
Lymphoma & Leukaemia Watch 51 – CLL17 Trial
Lymphoma & Leukaemia Practice Review Issue 4
Study Review – CAPTIVATE study update: Long-term efficacy and safety of fixed duration ibrutinib–venetoclax in patients with CLL or SLL
ASH Lymphoma & Leukaemia Highlights 2025
